Brief: Adagene Appoints Interim Chief Medical Officer
12/08/2021 12:49
Aug 12 (Reuters) - Adagene Inc 978y.F :
* ADAGENE ANNOUNCES APPOINTMENT OF INTERIM CHIEF MEDICAL
OFFICER
AND NEW MEMBERS OF SCIENTIFIC AND STRATEGIC ADVISORY BOARD
Source text for Eikon: ID:nGNX5kqxyn
Further company coverage: 978y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adagene
See all newsBrief: Adagene To Begin Phase 1 Study Of ADG138 For Advanced Solid Tumors In Q4 2026
Brief: Adagene Announces That Third Arc Bio Has Selected First Lead Candidate Under Amended Strategic Collaboration For Development Of Masked Cd3 T Cell Engagers Utilizing Safebody® Technology
Brief: Adagene Inc Announces Offering Of American Depositary Shares
Brief: Adagene Announces FDA Fast Track Designation For Muzastotug (Adg126)
Brief: Adagene Expands SAFEBody Deal With Exelixis To Develop Third Novel Masked Antibody-Drug Conjugate